SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Omthera Pharmaceuticals, Inc. Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies